This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Diabetes Mellitus, Type 2
and you are
between 18 and 80
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

A Phase 3b, open-label, randomized, multicenter, safety and tolerability study of ITCA 650 in subjects with Type 2 diabetes taking liraglutide and metformin.

Provided treatments

  • Drug: ITCA 650 Osmotic Mini Pump 20/60 mcg/day
  • Drug: ITCA 650 Osmotic Mini Pump 60 mcg/day
  • Drug: Metformin
  • Drug: Liraglutide

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02638805. The sponsor of the trial is Intarcia Therapeutics and it is looking for 136 volunteers for the current phase.
Official trial title:
An Open-Label, Multi-Center, Randomized, Phase 3b Study to Evaluate the Safety and Tolerability of Switching to One of Two Dosing Strategies of ITCA 650 in Patients With Type 2 Diabetes Receiving Stable Doses of Liraglutide